...教授是这篇论文的通讯作者。其擅长口腔颌面外科及头颈部肿瘤的诊断和治疗，尤其在头颈部肿瘤的手术治疗、口腔颌面部晚期恶性肿瘤侵犯颅底的颅颌面联合切除术，以及颌面部血管瘤的基础研究和临床诊治。 人类头颈部鳞癌(SCCHN)是全球第6位最常见的癌症类型，每年新增病例达60万例，死亡率约为50%。
基于144个网页-相关网页
在头颈部鳞癌 head and neck squamous carcinoma ; HNSCC
头颈部鳞状细胞癌 HNSCC ; SCCHN ; Head and neck squamous cell carcinoma
和pRb在头颈部鳞癌 HNSCC
局部晚期头颈部鳞癌 LASCCHN
对头颈部鳞状细胞癌 Head and neck squamous cell carcinoma
目的：探讨头颈部鳞癌的微卫星不稳定性(msi)及杂合性丢失(LOH)。
AIM: To examine the microsatellite instability (MSI) and loss of heterozygosity (LOH) in head and neck squamous cell carcinomas (HNSCC).
本文旨在观察西妥昔单抗联合放疗对中国局部晚期头颈部鳞癌患者的近期疗效和安全性。
This paper aims to observe the short term efficiency and safety of Cetuximab combined with radiotherapy of head and neck squamous Cell carcinoma in Chinese patients.
博莱霉素对头颈部鳞癌、恶性淋巴瘤有效，且不引起白细胞减少，不抑制机体免疫功能，也不损害造血系统。
BLM is effective in treatment of squama cancer of head and cervix, and malignant lymphoma without decreasing leucocytes, inhibiting immune functions and damaging hemopoietic system.
应用推荐